Registration - In-house Corporation

Gilead Sciences Canada / Christophe Griolet, V.P. and General Manager

Registration Information

In-house Corporation name: Gilead Sciences Canada
Responsible Officer Name: Christophe Griolet, V.P. and General Manager
Responsible Officer Change History
Initial registration start date: 2017-11-27
Registration status: Active
Registration Number: 953103-360912

Associated Communications

Total Number of Communication Reports: 51

Monthly communication reports in the last 6 months: 13

Version 12 of 12 (2024-04-15 to present)

Registration versions:

Version 12 of 12 (2024-04-15 to present)

Lobbying Information

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Health, Science and Technology	Canada Agency for Drugs and Technologies in Health (CADTH) as it relates to health economics assessment and recommendations made on new medicines.	Policies or Program
Aboriginal Affairs, Health	Federal Government First Nations and Inuit Health Branch program with respect to health services. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.	Policies or Program
Economic Development, Employment and Training, Health, Industry, Intellectual Property, Research and Development, Science and Technology	Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector	Policies or Program
Health, Industry, Intellectual Property, International Trade, Research and Development, Science and Technology	Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution.	Regulation, Legislative Proposal, Bill or Resolution
Aboriginal Affairs, Health, Immigration, Industry, Research and Development, Science and Technology	Policy and Programs Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19.	Policies or Program

Communication Techniques

Written communication
Oral communication

Government Institutions

Canadian Institutes of Health Research (CIHR)
Correctional Service of Canada (CSC)
Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Immigration, Refugees and Citizenship Canada (IRCC)
Indigenous Services Canada (ISC)
Innovation, Science and Economic Development Canada (ISED)
Patented Medicine Prices Review Board (PMPRB)
Privy Council Office (PCO)
Public Health Agency of Canada (PHAC)
Senate of Canada

In-house Corporation Details

Description of activities

Gilead Sciences Canada Inc. is the Canadian affiliate of Gilead Sciences inc. Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet need. The company has a focus within the HIV, hepatitis, antiviral agents for pandemic response for COVID-19, inflammatory diseases, oncology and respiratory therapeutic areas.

Responsible officer name and position during the period of this registration

Christophe Griolet, V.P. and General Manager

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
6925 Century Avenue, suite 400
Mississauga, ON L5N 7K2
Canada

Telephone number: 416-919-6379

Parent Company Information

Gilead Sciences Inc
- 333 Lakeside Dr
  Foster City, CA 94404
  United States of America

Subsidiary Beneficiary Information

Gilead Sciences Canada does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

No lobbyists added

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Bobby Sutherland, Sr. Director, Government Affairs | No public offices held

Gilead Sciences Canada/

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Gilead Sciences Canada/	2024-04-15	current
Gilead Sciences Canada/	2017-11-27	2024-04-15

Gilead Sciences Canada

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Christophe Griolet	2022-10-01	Current
Melissa Koomey	2020-01-06	2022-10-01
Kennet Brysting	2017-11-27	2020-01-06

Christophe Griolet, V.P. and General Manager (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-51 of 51

Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jennifer O'Connell, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2024-04-16
Posted date: 2024-05-15
Communication number: 360912-603078 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Laurel Chester, Senior Advisor | Innovation, Science and Economic Development Canada (ISED)
- jaxson Khan, Senior Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Industry
Communication date: 2024-04-16
Posted date: 2024-05-15
Communication number: 360912-603077 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Colin Deacon, Senator | Senate of Canada
Subject Matter of the communication: Economic Development, Health, Industry
Communication date: 2024-04-16
Posted date: 2024-05-15
Communication number: 360912-603076 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Brian Masse, Member of Parliament Windsor West | House of Commons
Subject Matter of the communication: Health, Industry, International Trade
Communication date: 2024-04-15
Posted date: 2024-05-15
Communication number: 360912-603074 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Etienne-Rene Massie, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- Andrea Johnston, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- Francis Bilodeau, Associate Deputy Minister | Office of the Associate Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Industry
Communication date: 2024-04-15
Posted date: 2024-05-15
Communication number: 360912-603053 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mark Schaan, Senior Assistant Deputy Minister | Strategy and Innovation Policy Sector - Assistant Deputy Minister's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development
Communication date: 2024-04-15
Posted date: 2024-05-15
Communication number: 360912-603050 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Fatima Asghar, Policy Advisor | Health Canada (HC)
- Wilder Walker-Stewart, Policy Advisor | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development, Federal-Provincial Relations
Communication date: 2024-03-04
Posted date: 2024-03-05
Communication number: 360912-595266 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Suzy McDonald, Associate Deputy Minister | Finance Canada (FIN)
Subject Matter of the communication: Economic Development, Health, Research and Development, Science and Technology
Communication date: 2023-12-12
Posted date: 2023-12-21
Communication number: 360912-589497 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Research and Development, Science and Technology
Communication date: 2023-12-12
Posted date: 2023-12-21
Communication number: 360912-589495 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- joel denis, Director General | Public Health Agency of Canada (PHAC)
- cindy evans, Vice President, | Public Health Agency of Canada (PHAC)
- Heather Jeffrey, President | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health, Industry, Research and Development, Federal-Provincial Relations
Communication date: 2023-12-12
Posted date: 2023-12-21
Communication number: 360912-589492 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jean-Sebastien Bock, Deputy Chief of Staff and Director of Policy | Office of the Minister of Health | Health Canada (HC)
- Eshan Naik, Director of Policy | Office of the Leader of the Government in the House of Commons | House of Commons
Subject Matter of the communication: Economic Development, Health, Industry, Research and Development
Communication date: 2023-12-12
Posted date: 2023-12-21
Communication number: 360912-589491 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dr. Stephen Lucas, Deputy Minister | Health Canada (HC)
Subject Matter of the communication: Economic Development, Health, Industry, Research and Development, International Trade
Communication date: 2023-12-12
Posted date: 2023-12-21
Communication number: 360912-589485 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jennifer Miller, Assistant Secretary to Cabinet, Social Development Policy Branch | Privy Council Office (PCO)
Subject Matter of the communication: Economic Development, Health, Research and Development
Communication date: 2023-12-12
Posted date: 2023-12-21
Communication number: 360912-589484 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mohamed-Iqbal Ravalia, Senator | Senate of Canada
Subject Matter of the communication: Health, Research and Development, Science and Technology
Communication date: 2023-11-28
Posted date: 2023-12-15
Communication number: 360912-586332 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Wilder Walker-Stewart, Policy Advisor | Health Canada (HC)
- Eshan Naik, Director of Policy | Health Canada (HC)
Subject Matter of the communication: Health, Science and Technology, Aboriginal Affairs
Communication date: 2023-11-20
Posted date: 2023-11-21
Communication number: 360912-584771 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mike Burton, Chief of staff | Immigration, Refugees and Citizenship Canada (IRCC)
Subject Matter of the communication: Health, Federal-Provincial Relations
Communication date: 2023-11-20
Posted date: 2023-12-15
Communication number: 360912-584770 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- René Cormier, Senator | Senate of Canada
- Mohamed-Iqbal Ravalia, Senator | Senate of Canada
Subject Matter of the communication: Health
Communication date: 2023-10-04
Posted date: 2023-11-15
Communication number: 360912-577896 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Industry, Research and Development, Science and Technology
Communication date: 2023-09-20
Posted date: 2023-10-16
Communication number: 360912-577895 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mohamed-Iqbal Ravalia, Senator | Senate of Canada
Subject Matter of the communication: Health, Research and Development
Communication date: 2023-05-02
Posted date: 2023-06-15
Communication number: 360912-564878 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- René Cormier, Senator | Senate of Canada
Subject Matter of the communication: Health, Research and Development, Science and Technology
Communication date: 2023-05-02
Posted date: 2023-06-15
Communication number: 360912-564875 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Daniel MacDonald, Director General, Drugs for Rare Diseases | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development
Communication date: 2023-04-25
Posted date: 2023-05-15
Communication number: 360912-564891 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bianca Hossain, Policy Head, Life Sciences | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Science and Technology
Communication date: 2023-04-25
Posted date: 2023-05-15
Communication number: 360912-564890 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- David Boudreau, Director General | Health Canada (HC)
Subject Matter of the communication: Health, Science and Technology
Communication date: 2023-04-25
Posted date: 2023-05-15
Communication number: 360912-564887 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ed Morgan, Director General, Policy | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development, Science and Technology
Communication date: 2023-04-25
Posted date: 2023-05-15
Communication number: 360912-564885 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jocelyne Voisin, ADM, Strategic Policy Branch | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development, Science and Technology
Communication date: 2023-04-25
Posted date: 2023-05-15
Communication number: 360912-564884 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
Communication date: 2023-04-24
Posted date: 2023-05-15
Communication number: 360912-564889 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stephen Ellis, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Research and Development
Communication date: 2023-04-24
Posted date: 2023-05-15
Communication number: 360912-564882 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jordan Ames-Sinclair, Special Assistant, Policy | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development
Communication date: 2023-03-27
Posted date: 2023-04-15
Communication number: 360912-561934 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Allison Haley, Director of Parliamentary Affairs | House of Commons
- Stephen Ellis, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Research and Development, Science and Technology
Communication date: 2022-12-08
Posted date: 2023-01-16
Communication number: 360912-550283 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)
- Jordan Ames-Sinclair, Special Assistant, Policy | Health Canada (HC)
- Jean-Yves Duclos, Minister of Health | Health Canada (HC)
Subject Matter of the communication: Economic Development, Health, Industry, Research and Development, Science and Technology
Communication date: 2022-12-06
Posted date: 2023-01-16
Communication number: 360912-550277 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
- Eric Costen, Senior Assistant Deputy Minister | Industry Sector | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Industry, Research and Development, Science and Technology
Communication date: 2022-11-18
Posted date: 2022-12-15
Communication number: 360912-548140 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Caroline Menard, Manager | Innovation, Science and Economic Development Canada (ISED)
- Benoit Leduc, Manager | Innovation, Science and Economic Development Canada (ISED)
- Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
- Eric Costen, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Industry, Research and Development, Science and Technology
Communication date: 2022-11-18
Posted date: 2022-12-15
Communication number: 360912-548029 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jordan Ames-Sinclair , Special Assistant, Policy | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development
Communication date: 2022-09-20
Posted date: 2022-10-15
Communication number: 360912-542939 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Randy Boissonnault, Minister of Tourism and Associate Minister of Finance | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology, International Trade
Communication date: 2022-08-08
Posted date: 2022-09-15
Communication number: 360912-540804 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jean-Yves Duclos, Minister of Health | Health Canada (HC)
- Jordan Ames-Sinclair, Director of Policy and Stakeholder Relations | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development, Science and Technology
Communication date: 2022-08-02
Posted date: 2022-09-15
Communication number: 360912-540813 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)
- Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2022-05-31
Posted date: 2022-06-15
Communication number: 360912-533180 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Adam Van Koeverden, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-05-31
Posted date: 2022-06-15
Communication number: 360912-533179 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dr. Stephen Ellis, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-05-31
Posted date: 2022-06-15
Communication number: 360912-533178 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Eric Costen, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Industry, Research and Development, Science and Technology
Communication date: 2022-05-30
Posted date: 2022-06-15
Communication number: 360912-533177 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2022-04-14
Posted date: 2022-05-16
Communication number: 360912-530084 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rechie Valdez, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Science and Technology
Communication date: 2022-01-11
Posted date: 2022-02-15
Communication number: 360912-519163 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jamie Kippen, Chief of Staff | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-01-10
Posted date: 2022-02-15
Communication number: 360912-519162 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Hendrik Brakel, Chief Economic Advisor | Office of the Leader of the Opposition, House of Commons | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2021-07-14
Posted date: 2021-07-14
Communication number: 360912-510589 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Patrick Weiler, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Science and Technology
Communication date: 2021-07-08
Posted date: 2021-07-12
Communication number: 360912-510099 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Marcus Powlowski, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2021-05-27
Posted date: 2021-05-28
Communication number: 360912-506413 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Andrew Lui, Members Assistant | House of Commons
Subject Matter of the communication: Health, Industry, Science and Technology
Communication date: 2021-03-31
Posted date: 2021-03-31
Communication number: 360912-500391 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bari Miller, Legislative Manager to Hon. Michelle Rempel Garner | House of Commons
- Julia Parsons, Operations Manager to Hon. Michelle Rempel Garner | House of Commons
Subject Matter of the communication: Economic Development, Health, Research and Development
Communication date: 2021-03-15
Posted date: 2021-03-22
Communication number: 360912-500055 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sabina Saini, Chief of Staff | Minister's office | Health Canada (HC)
- Kathryn Nowers, Director of Policy | Minister's office | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2021-02-24
Posted date: 2021-03-02
Communication number: 360912-497087 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Supriya Sharma, Chief Medical Officer, Health Canada | Health Products and Foods Branch | Health Canada (HC)
- Evelyn Soo, Director | Health Products and Food Branch | Health Canada (HC)
- Jacqueline Arthur, Senior Manager, Policy Development | AMR Division | Public Health Agency of Canada (PHAC)
- Linsey Hollett, Director General | Health Product Compliance and Risk Management | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2021-02-08
Posted date: 2021-02-12
Communication number: 360912-495297 (amended from 360912-495288) View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ziad Aboultaif, Member of Parliament | House of Commons
Subject Matter of the communication: Economic Development, Health, Research and Development, Science and Technology
Communication date: 2021-01-13
Posted date: 2021-01-28
Communication number: 360912-494029 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Navdeep Bains, Minister | Innovation, Science and Economic Development Canada (ISED)
- Susan Bincoletto, Ambassador of Canada to Switzerland and Liechtenstein | Global Affairs Canada (GAC)
- Gianluca Cairo, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Research and Development, International Trade
Communication date: 2018-01-23
Posted date: 2018-02-15
Communication number: 360912-420061 View associated registration

Christophe Griolet, V.P. and General Manager (Corporation)

Learn more...

Results below are sorted by posted date, beginning with the most recent.

Results 1-51 of 51

Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jennifer O'Connell, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2024-04-16
Posted date: 2024-05-15
Communication number: 360912-603078 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Laurel Chester, Senior Advisor | Innovation, Science and Economic Development Canada (ISED)
- jaxson Khan, Senior Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Industry
Communication date: 2024-04-16
Posted date: 2024-05-15
Communication number: 360912-603077 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Colin Deacon, Senator | Senate of Canada
Subject Matter of the communication: Economic Development, Health, Industry
Communication date: 2024-04-16
Posted date: 2024-05-15
Communication number: 360912-603076 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Brian Masse, Member of Parliament Windsor West | House of Commons
Subject Matter of the communication: Health, Industry, International Trade
Communication date: 2024-04-15
Posted date: 2024-05-15
Communication number: 360912-603074 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Etienne-Rene Massie, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- Andrea Johnston, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- Francis Bilodeau, Associate Deputy Minister | Office of the Associate Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Industry
Communication date: 2024-04-15
Posted date: 2024-05-15
Communication number: 360912-603053 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mark Schaan, Senior Assistant Deputy Minister | Strategy and Innovation Policy Sector - Assistant Deputy Minister's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development
Communication date: 2024-04-15
Posted date: 2024-05-15
Communication number: 360912-603050 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Fatima Asghar, Policy Advisor | Health Canada (HC)
- Wilder Walker-Stewart, Policy Advisor | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development, Federal-Provincial Relations
Communication date: 2024-03-04
Posted date: 2024-03-05
Communication number: 360912-595266 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Suzy McDonald, Associate Deputy Minister | Finance Canada (FIN)
Subject Matter of the communication: Economic Development, Health, Research and Development, Science and Technology
Communication date: 2023-12-12
Posted date: 2023-12-21
Communication number: 360912-589497 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Research and Development, Science and Technology
Communication date: 2023-12-12
Posted date: 2023-12-21
Communication number: 360912-589495 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- joel denis, Director General | Public Health Agency of Canada (PHAC)
- cindy evans, Vice President, | Public Health Agency of Canada (PHAC)
- Heather Jeffrey, President | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health, Industry, Research and Development, Federal-Provincial Relations
Communication date: 2023-12-12
Posted date: 2023-12-21
Communication number: 360912-589492 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jean-Sebastien Bock, Deputy Chief of Staff and Director of Policy | Office of the Minister of Health | Health Canada (HC)
- Eshan Naik, Director of Policy | Office of the Leader of the Government in the House of Commons | House of Commons
Subject Matter of the communication: Economic Development, Health, Industry, Research and Development
Communication date: 2023-12-12
Posted date: 2023-12-21
Communication number: 360912-589491 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dr. Stephen Lucas, Deputy Minister | Health Canada (HC)
Subject Matter of the communication: Economic Development, Health, Industry, Research and Development, International Trade
Communication date: 2023-12-12
Posted date: 2023-12-21
Communication number: 360912-589485 View associated registration
Gilead Sciences Canada
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jennifer Miller, Assistant Secretary to Cabinet, Social Development Policy Branch | Privy Council Office (PCO)
Subject Matter of the communication: Economic Development, Health, Research and Development
Communication date: 2023-12-12
Posted date: 2023-12-21
Communication number: 360912-589484 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

Gilead Sciences Canada / Christophe Griolet, V.P. and General Manager

Registration Information

Associated Communications

Version 12 of 12 (2024-04-15 to present)

Version 12 of 12 (2024-04-15 to present)

Subject Matter Details

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties